Literature DB >> 19159959

Cerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalo-myo-synangiosis in moyamoya disease.

Miki Fujimura1, Tomohiro Kaneta, Hiroaki Shimizu, Teiji Tominaga.   

Abstract

Compression of the brain by swollen temporal muscle used for indirect pial synangiosis is a rare complication after the revascularization surgery for moyamoya disease, and its mechanism and clinical presentation are undetermined. A 26-year-old woman, who had been suffering transient ischemic attack (TIA), underwent superficial temporal artery-middle cerebral artery anastomosis with encephalo-myo-synangiosis (EMS) on the affected hemisphere. The (123)I-IMP-SPECT 1 day after surgery demonstrated an improvement of cerebral blood flow (CBF) on the operated hemisphere. Two days later, however, she suffered fluctuating aphasia when computed tomography scan revealed marked swelling of the temporal muscle used for EMS. The (123)I-IMP-SPECT 4 days after surgery showed significant decrease in CBF by the compression of the brain. Then, we performed revision of EMS. The base of the temporal muscle was markedly compressed by the edge of the free bone flap, which resulted in swelling of the entire temporal muscle used for EMS. We drilled out the edge of the free bone flap for decompression. Her aphasia disappeared postoperatively, and CBF normalized 7 days after the initial surgery. Her TIA disappeared, and there was no deterioration during the follow-up period. The STA-MCA bypass has been patent since the initial surgery. Surgical revascularization including EMS has a substantial risk for cerebral ischemia owing to compression of the brain by temporal muscle swelling. Relative wide bone window for temporal muscle insertion is necessary to avoid this rare complication. Once the flow compromise is confirmed, we recommend early decompression by the revision of EMS.

Entities:  

Mesh:

Year:  2009        PMID: 19159959     DOI: 10.1007/s10143-009-0184-6

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  13 in total

1.  [Intraoperative brain surface blood flow monitoring using IRIS V thermographic imaging system in patients with Moyamoya disease].

Authors:  Atsuhiro Nakagawa; Miki Fujimura; Tomohiro Ohki; Hideaki Suzuki; Kazuyoshi Takayama; Teiji Tominaga
Journal:  No Shinkei Geka       Date:  2006-10

2.  Multiple burr-hole operation for adult moyamoya disease.

Authors:  T Kawaguchi; S Fujita; K Hosoda; Y Shose; S Hamano; M Iwakura; N Tamaki
Journal:  J Neurosurg       Date:  1996-03       Impact factor: 5.115

3.  Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications.

Authors:  K Houkin; T Ishikawa; T Yoshimoto; H Abe
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

4.  Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Shunji Mugikura; Hiroaki Shimizu; Teiji Tominaga
Journal:  Surg Neurol       Date:  2007-03

5.  Postoperative temporary neurological deficits in adults with moyamoya disease.

Authors:  Shiro Ohue; Yoshiaki Kumon; Kanehisa Kohno; Hideaki Watanabe; Shiinji Iwata; Takanori Ohnishi
Journal:  Surg Neurol       Date:  2007-11-08

6.  Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Hiroaki Shimizu; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2007-05-08       Impact factor: 1.475

7.  Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2007-12-08       Impact factor: 1.475

8.  Cerebral ischemia due to compression of the brain by ossified and hypertrophied muscle used for encephalomyosynangiosis in childhood moyamoya disease.

Authors:  Hajime Touho
Journal:  Surg Neurol       Date:  2007-10-29

9.  Focal hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease. Case report.

Authors:  Kazuhide Furuya; Nobutaka Kawahara; Akio Morita; Toshimitsu Momose; Shigeki Aoki; Takaaki Kirino
Journal:  J Neurosurg       Date:  2004-01       Impact factor: 5.115

10.  Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey.

Authors:  Shinichi Kuriyama; Yasuko Kusaka; Miki Fujimura; Kenji Wakai; Akiko Tamakoshi; Shuji Hashimoto; Ichiro Tsuji; Yutaka Inaba; Takashi Yoshimoto
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

View more
  10 in total

1.  Active endocytosis and microtubule remodeling restore compressed pyramidal neuron morphology in rat cerebral cortex.

Authors:  Shih-Hao Huang; Yueh-Jan Wang; Guo-Fang Tseng; Han-Chen Ho
Journal:  Cell Mol Neurobiol       Date:  2012-03-30       Impact factor: 5.046

2.  Intra-operative hemorrhage due to hyperperfusion during direct revascularization surgery in an adult patient with moyamoya disease: a case report.

Authors:  Hiroki Uchida; Hidenori Endo; Miki Fujimura; Toshiki Endo; Kuniyasu Niizuma; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2017-06-09       Impact factor: 3.042

3.  Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management.

Authors:  Sherif Rashad; Miki Fujimura; Kuniyasu Niizuma; Hidenori Endo; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2016-05-16       Impact factor: 3.042

4.  Arachnoid Membrane Suturing for Prevention of Subdural Fluid Collection in Extracranial-intracranial Bypass Surgery.

Authors:  Gun Woo Kim; Sung Pil Joo; Tae Sun Kim; Hyung Sik Moon; Jae Won Jang; Bo Ra Seo; Jung Kil Lee; Jae Hyoo Kim; Soo Han Kim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2014-06-30

Review 5.  Significance of Cerebral Blood Flow Analysis in the Acute Stage after Revascularization Surgery for Moyamoya Disease.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-09-15       Impact factor: 1.742

6.  The Efficacy of Single Barrel Superficial Temporal Artery-middle Cerebral Artery Bypass in Treatment of Adult Patients with Ischemic-type Moyamoya Disease.

Authors:  Mahnjeong Ha; Chang Hwa Choi; Jae Il Lee; Seung Heon Cha; Sang Weon Lee; Jun Kyeung Ko
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2016-09-30

7.  Paradoxical symptomatic cerebral blood flow decreases after combined revascularization surgery for patients with pediatric moyamoya disease: illustrative case.

Authors:  Yoshio Araki; Kinya Yokoyama; Kenji Uda; Fumiaki Kanamori; Michihiro Kurimoto; Yoshiki Shiba; Takashi Mamiya; Kai Takayanagi; Kazuki Ishii; Masahiro Nishihori; Kazuhito Takeuchi; Kuniaki Tanahashi; Yuichi Nagata; Yusuke Nishimura; Sho Okamoto; Masaki Sumitomo; Takashi Izumi; Ryuta Saito
Journal:  J Neurosurg Case Lessons       Date:  2022-01-17

8.  Use of a panel of four microRNAs in CSF as a predicted biomarker for postoperative neoangiogenesis in moyamoya disease.

Authors:  Gang Wang; Yunyu Wen; Siyuan Chen; Guozhong Zhang; Mingzhou Li; Shichao Zhang; Songtao Qi; Wenfeng Feng
Journal:  CNS Neurosci Ther       Date:  2021-05-04       Impact factor: 5.243

Review 9.  Severe cerebral edema induced by watershed shift after bypass in a patient with chronic steno-occlusive disease: a case report and short literature review.

Authors:  Yin Li; Yu-Yu Wei; Yang Cao; Xiao-Yang Lu; Yuan Yao; Lin Wang
Journal:  BMC Neurol       Date:  2020-09-05       Impact factor: 2.474

Review 10.  Limits and pitfalls of indirect revascularization in moyamoya disease and syndrome.

Authors:  Pietro Fiaschi; Marcello Scala; Gianluca Piatelli; Domenico Tortora; Francesca Secci; Armando Cama; Marco Pavanello
Journal:  Neurosurg Rev       Date:  2020-09-21       Impact factor: 3.042

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.